Induction of hepatic and renal metallothionein synthesis by ferric nitrilotriacetate in mice: the role of MT as an antioxidant.
Metallothionein (MT) demonstrates strong antioxidant properties, yet the physiological relevance of its antioxidant action is not clear. Injection of mice with ferric nitrilotriacetate (Fe-NTA) caused a dose-dependent increase in hepatic and renal MT. Fe-NTA caused a greater increase in hepatic and renal MT concentration (2.5- and 4-fold) compared with FeCl(3) at the same dose of ferric ion. MT mRNA levels were markedly elevated in both of tissues. Thiobarbituric acid (TBA) values in both tissues reached a maximum after 2-4 h. The MT concentrations were significantly increased after 2-4 h in liver and after 8-16 h in kidneys. Plasma concentrations of cytokines such as IL-6 and TNFalpha were elevated by 4 h; IL-6 levels were 24 times higher after Fe-NTA than that after injection of FeCl(3). Pretreatment of mice with ZnSO(4) attenuated nephrotoxicity induced by Fe-NTA after 2 h, but was not effective 4 h after injection. After a Fe-NTA injection, a loss of Cd-binding properties of preinduced MT was observed only in kidneys of Zn-pretreated mice but not in liver. Treatment with BSO, glutathione (GSH) depletor, intensified a loss of its Cd-binding properties after a Fe-NTA injection. These results indicate that induction of MT synthesis may result from reactive oxygen species (ROS) generated by Fe-NTA, and MT may act in vivo as a complementary antioxidant.
Min
Kyong-Son
KS
Faculty of Nutrition, Kobe Gakuin University, Ikawadani-cho, Kobe, 651-2180, Japan. min@nutr.kobegakuin.ac.jp
Morishita
Fumio
F
Tetsuchikawahara
Noriko
N
Onosaka
Satomi
S
D000818:Animals; D000975:Antioxidants / Q000378:metabolism*; D001729:Bismuth; D001806:Blood Urea Nitrogen; D001959:Bromates / Q000633:toxicity; D002104:Cadmium / Q000378:metabolism; D002712:Chlorides; D005290:Ferric Compounds / Q000008:administration & dosage / Q000633:toxicity*; D015850:Interleukin-6 / Q000096:biosynthesis / Q000097:blood; D007668:Kidney / Q000187:drug effects / Q000378:metabolism*; D015227:Lipid Peroxidation; D008099:Liver / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D008668:Metallothionein / Q000096:biosynthesis / Q000378:metabolism*; D051379:Mice; D008815:Mice, Inbred Strains; D009153:Mutagens / Q000633:toxicity*; D009571:Nitrilotriacetic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000633:toxicity*; D013997:Time Factors; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis / Q000096:biosynthesis; D015032:Zinc
D000975:Antioxidants; D001959:Bromates; D002712:Chlorides; D005290:Ferric Compounds; D015850:Interleukin-6; D009153:Mutagens; D014409:Tumor Necrosis Factor-alpha; D002104:Cadmium; C019536:potassium bromate; D008668:Metallothionein; D015032:Zinc; D009571:Nitrilotriacetic Acid; D001729:Bismuth; C024555:ferric chloride; C020326:ferric nitrilotriacetate